InMed Pharmaceuticals Inc. (INM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.17M |
| Enterprise Value | -10.91M |
| P/E Ratio | -0 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.67 |
| Price/Book Ratio | 0.88 |
| Enterprise/Revenue | -0.5 |
| Enterprise/EBITDA | 0.22 |
Fiscal Year
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -2.46 |
| Operating Margin | -2.47 |
AD
Management Effectiveness
| Return On Assets | -1.09 |
| Return On Equity | -0.73 |
Income Statement
| Revenue | 4.94M |
| Revenue/Share | 0.99 |
| Gross Profit | 1.71M |
| EBITDA | -7.26M |
| Net Income | -8.16M |
| Diluted EPS | -8.36 |
Balance Sheet
| Total Cash | 5.2M |
| Total Cash/Share | 1.28 |
| Total Debt | 420,147 |
| Total Debt/Equity | 0.06 |
| Current Ratio | 3.11 |
| Book Value Per Share | 1.7 |
Price History
| 52-Week Change | -38.78 |
| 52-Week High | 5.5 |
| 52-Week Low | 0.57 |
| Moving Average 50 Days | 1.11 |
| Moving Average 200 Days | 1.33 |
Statistics
| Average Volume | 1.66M |
| Shares Outstanding | 1.81M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | November 14, 2024 |
AD
